Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | N/A | 13,544 | N/A | N/A | N/A |
| Gross Profit | N/A | 13,544 | N/A | N/A | N/A |
| Operating Expenses | 11,575 | 8,253 | 6,782 | 15,247 | 17,342 |
| Operating Income | -11,575 | 5,291 | -6,782 | -15,247 | -17,342 |
| Other Income | 759 | -2,218 | 4,343 | 1,389 | 3,196 |
| Pre-tax Income | -10,816 | 3,073 | -2,439 | -13,858 | -14,146 |
| Income Tax | 0 | 0 | -631 | -1,844 | -749 |
| Net Income Continuous | -10,816 | 3,073 | -1,808 | -12,014 | -13,397 |
| Net Income | $-10,816 | $3,073 | $-1,808 | $-12,014 | $-13,397 |
| EPS Basic Total Ops | -0.11 | 0.03 | -0.02 | -0.14 | -0.16 |
| EPS Basic Continuous Ops | -0.11 | 0.03 | -0.02 | -0.14 | -0.16 |
| EPS Diluted Total Ops | -0.11 | 0.03 | -0.02 | -0.14 | -0.16 |
| EPS Diluted Continuous Ops | -0.11 | 0.03 | -0.02 | -0.14 | -0.16 |
| EBITDA(a) | $-11,571 | $5,369 | $-6,704 | $-15,167 | $-17,252 |